*<p>: <i>p</i><0.05,</p>**<p>: <i>p</i><0.01 compared with control group (NanoX).</p
<p>Data are expressed as means ± SD (n = 10).</p><p>*: <i>p<0.05,</i> compared with that in control ...
<p>HepG2 xenograft-bearing SCID mice (10 mice per group) were intravenously (<i>i</i>.<i>v</i>.) inj...
<p>Mice were monitored for survival. Survival data are plotted on a Kaplan-Meier curve (A). Treatmen...
<p>The mice bearing large tumor (<i>n</i> = 9 for each group, A) and those bearing small tumor (<i>n...
<p>The mice bearing large tumor (<i>n</i> = 9 for each group, tumor volume 102.4±22.0 mm<sup>3</sup>...
<p>(A) Suppression of tumor growth measured by volume in each treatment group. Points, mean; bars, S...
<p>N – number of mice per group, *p<0.05 as compared to the results for mice treated with 9 mg/kg fr...
<p>Mice were treated with liposomal drugs (NanoVNB, InNanoX, InVNBL and NanoX as a control) at Day 0...
<p>BALB/c mice were immunized with the hTM4SF5R2-3 peptide and Lipoplex(O) complex or indicated comb...
PURPOSE: PEGylated liposomes are important drug carriers that can passively target tumor by enhanced...
Purpose: PEGylated liposomes are important drug carriers that can passively target tumor by enhanced...
[[abstract]]Purpose: PEGylated liposomes are important drug carriers that can passively target tumor...
[[abstract]]Objectives PEGylated liposomes are important drug carriers, which can passively target t...
<p>(A) The survival as a function of time of the tumor-bearing mice of the DOX-PGMNPs-M group. (B)Th...
<p>(<b>A, B</b>) Comparison of tumor growth suppression with Cisplatin, F0-Liposome-Cisplatin, and F...
<p>Data are expressed as means ± SD (n = 10).</p><p>*: <i>p<0.05,</i> compared with that in control ...
<p>HepG2 xenograft-bearing SCID mice (10 mice per group) were intravenously (<i>i</i>.<i>v</i>.) inj...
<p>Mice were monitored for survival. Survival data are plotted on a Kaplan-Meier curve (A). Treatmen...
<p>The mice bearing large tumor (<i>n</i> = 9 for each group, A) and those bearing small tumor (<i>n...
<p>The mice bearing large tumor (<i>n</i> = 9 for each group, tumor volume 102.4±22.0 mm<sup>3</sup>...
<p>(A) Suppression of tumor growth measured by volume in each treatment group. Points, mean; bars, S...
<p>N – number of mice per group, *p<0.05 as compared to the results for mice treated with 9 mg/kg fr...
<p>Mice were treated with liposomal drugs (NanoVNB, InNanoX, InVNBL and NanoX as a control) at Day 0...
<p>BALB/c mice were immunized with the hTM4SF5R2-3 peptide and Lipoplex(O) complex or indicated comb...
PURPOSE: PEGylated liposomes are important drug carriers that can passively target tumor by enhanced...
Purpose: PEGylated liposomes are important drug carriers that can passively target tumor by enhanced...
[[abstract]]Purpose: PEGylated liposomes are important drug carriers that can passively target tumor...
[[abstract]]Objectives PEGylated liposomes are important drug carriers, which can passively target t...
<p>(A) The survival as a function of time of the tumor-bearing mice of the DOX-PGMNPs-M group. (B)Th...
<p>(<b>A, B</b>) Comparison of tumor growth suppression with Cisplatin, F0-Liposome-Cisplatin, and F...
<p>Data are expressed as means ± SD (n = 10).</p><p>*: <i>p<0.05,</i> compared with that in control ...
<p>HepG2 xenograft-bearing SCID mice (10 mice per group) were intravenously (<i>i</i>.<i>v</i>.) inj...
<p>Mice were monitored for survival. Survival data are plotted on a Kaplan-Meier curve (A). Treatmen...
DOI
Add to ORKG